California Voters Will Have Their Say On Drug Prices
Heated battle expected over November ballot proposal to curb state’s prescription drug costs, as pharmaceutical industry opens its pocketbook to defeat the measure.
Drugs
1,301-1,318 of 1,318 results
-
-
Want Into A Clinical Trial? Read This First.
Experimental drugs might help desperate patients, but don’t count on an easy cure.
By Emily Bazar -
Research Gives Context To Addressing Nation’s Drug Abuse Crisis, Review Finds
As presidential candidates, state officials and even President Barack Obama wrestle with how to handle drug addiction, scientists lay out some of the intersections between opioid prescriptions and heroin abuse in the New England Journal of Medicine, including findings that crackdowns on opioid prescriptions may not fuel increases in heroin use.
-
Health Plans’ Coverage Of Some Drugs Can Be A Source Of Consumer Confusion
Some medicines, particularly intravenous treatments, are not listed in plans’ pharmacy benefit section and, therefore, it’s difficult to confirm coverage specifics.
-
Broader Strategies Necessary To Counter Painkiller Over Prescribing, Researchers Say
A research letter published Monday in JAMA Internal Medicine says opioid-prescribing practices are consistent with that of other medications.
-
Testing For Hepatitis C In Prisons Could Save Many Lives On The Outside
Treating Hep C is expensive, but new drugs can quickly cure the disease, ultimately saving money.
-
Most Americans See Personal Tie To Rising Prescription Painkiller Abuse
A new Kaiser Family Foundation tracking poll reports 16 percent say they know someone who died from a prescription painkiller overdose.
-
Fewer Medicare-Subsidized Drug Plans Means Less Choice For Low-Income Seniors
The number of Medicare plans that cover medications with a subsidy provided for low-income beneficiaries is declining in 2016 by 20 percent.
By Susan Jaffe -
Cancer Meds Often Bring Big Out-Of-Pocket Costs For Patients, Report Finds
The advocacy arm of the American Cancer Society said Wednesday that federal and state governments should move to restrict insurers from charging patients a percentage of the cost of their prescription drugs.
-
Study Finds Marketplace Silver Plans Offer Poor Access To HIV Drugs
Only 16 percent of the popular plans cover all 10 of the most common drug regimens and charge less than $100 a month in consumer cost sharing, according to a report by Avalere Health.
-
‘Do The Math’ When Shopping For A Health Plan This Open Enrollment Season
Because of the complexity of insurance available through healthcare.gov and state exchanges, and the broad variation in how prescription drugs are covered, experts encourage consumers to compare options to figure out which one best fits their needs.
-
Poll: Majority Of Americans Agree That The FDA Should Review Drug Ads Before They Air
Nearly eight in 10 say they have seen or heard these ads, and more than a quarter have discussed one of the drugs with a physician as a result.
-
Seniors Who Don’t Consider Switching Drug Plans May Face Steep Price Rise
For beneficiaries, staying in their current plans could prove costly so advocates urge them to check out the alternatives.
-
No Ready-Made Rx For Rising Drug Costs
Lawmakers, insurers and others have floated proposals to combat the spike in prescription drug prices, but will any of them gain traction?
-
Don’t Just Renew Your Medicare Plan. Shopping Around Can Save Money.
Enrollment for private Medicare Advantage and Part D drug plans begins Oct. 15 and consumer advocates urge seniors to check out prices to find the best deals.
By Susan Jaffe -
Express Scripts To Cover Pricey New Cholesterol Drugs
To control costs, the nation's largest pharmacy benefits manager has in place strict rules on which patients will be eligible.
-
Clinton Seeks To Build On Health Law, But Does She Have The Rx For Rising Health Costs?
The Democratic president candidate’s proposals to save consumers money are questioned by experts and health industry officials.
By Julie Rovner -
New Heart Failure Treatments Would Drive Up Short-Term Health Spending, Report Says
In an analysis, the Institute for Clinical and Economic Review concluded that price cuts are needed to control the budgetary impact.